Experience With Combination of Nimotuzumab and Intensity-Modulated Radiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s93238
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Informa UK Limited